Frankly, considering the fact that ABT's guidance on the low end is a bit n=more bearish than "Street" consensus, the stock is holding up remarkably well. This could be one of those extraordinary instances where the stock is simply washed out.
ABT has always, and will always, trade in a reliable price wave: buy in the mid/high 40s...sell in the low 50s. Once the dividend is declared in mid-February, I suspect the stock will begin to rise on the bullish news, as post-declaration, ABT will likely be yielding 4% ( assuming a flat share price until said declaration date ).
While guidance is on the low end, you whould keep in mind that at a P/E of just 12 on that guidance, we should be in the mid 50s. In the near term, we could go down on technicals, but this stock is still at a very attractive price.
The guidance is very conservative because of the Solvay acquisition. Earnings this morning after one time adjustments were a buck thirty, best quarter in three years, and revenues were up significantly. This is an overreaction and a gift. I added at 47.50 (dumb in hindsight), and I have limit orders down to 46. There is the very beginning of a sector rotation into healthcare if you need another reason to buy.